297 related articles for article (PubMed ID: 10731269)
1. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
Fugit MD; Rubal BJ; Donovan DJ
J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of nicardipine and esmolol on the cardiac cycle, intracardiac hemodynamic and endothelial shear stress in patients with unstable angina pectoris and moderate coronary stenosis: results from single center, randomized study.
Chen SL; Hu ZY; Zhang JJ; Ye F; Kan J; Xu T; Liu ZZ; Zhang YJ; Zhang JX; Chen M
Cardiovasc Ther; 2012 Jun; 30(3):162-71. PubMed ID: 22099625
[TBL] [Abstract][Full Text] [Related]
4. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
Ezra D; Boyd LM; Goldstein RE; Feuerstein G
J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457
[TBL] [Abstract][Full Text] [Related]
6. Changes in human coronary flow reserve after administration of intracoronary diltiazem.
Vrolix MC; Sionis D; Piessens J; Van Lierde J; Willems JL; De Geest H
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S64-7. PubMed ID: 1725547
[TBL] [Abstract][Full Text] [Related]
7. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
Lim SH; Anantharaman V; Teo WS; Chan YH
Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
[TBL] [Abstract][Full Text] [Related]
8. REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER).
Huang D; Qian J; Ge L; Jin X; Jin H; Ma J; Liu Z; Zhang F; Dong L; Wang X; Yao K; Ge J
Am Heart J; 2012 Sep; 164(3):394-401. PubMed ID: 22980307
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention.
Huang RI; Patel P; Walinsky P; Fischman DL; Ogilby JD; Awar M; Frankil C; Savage MP
Catheter Cardiovasc Interv; 2006 Nov; 68(5):671-6. PubMed ID: 17034064
[TBL] [Abstract][Full Text] [Related]
10. Influence of calcium channel antagonist therapy on the ischemic response to acute coronary occlusion in humans.
Kern MJ
Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III77-85. PubMed ID: 2691144
[TBL] [Abstract][Full Text] [Related]
11. [Differential therapy with calcium antagonists. Hemodynamic studies using nifedipine, verapamil and diltiazem].
Lehmann HU; Hochrein H
Dtsch Med Wochenschr; 1985 Apr; 110(17):674-80. PubMed ID: 3987531
[TBL] [Abstract][Full Text] [Related]
12. The comparative effects of calcium channel blockers in an experimental colitis model in rats.
Zeytunlu M; Korkut M; Akgün E; Firat O; Aynaci M; Içöz G; Kiliç M; Ersin S; Ozütemiz O
Turk J Gastroenterol; 2004 Dec; 15(4):243-9. PubMed ID: 16249979
[TBL] [Abstract][Full Text] [Related]
13. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
14. [Comparison between diltiazem and nicardipine used during anesthesia for coronary revascularization].
Furuya Y; Atarashi K; Tachibana C; Kobayashi N; Satoh K; Ohe Y
Masui; 1994 Apr; 43(4):523-8. PubMed ID: 8189616
[TBL] [Abstract][Full Text] [Related]
15. Comparative haemodynamic effects of nicardipine and verapamil in coronary artery disease.
Silke B; Verma SP; Hussain M; Jackson NC; Hafizullah M; Reynolds G; Taylor SH
Herz; 1985 Apr; 10(2):112-9. PubMed ID: 3872835
[TBL] [Abstract][Full Text] [Related]
16. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
Frishman WH; Charlap S
Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of diltiazem, verapamil, nifedipine, and nicardipine on sympathetic tachycardia in decentralized hearts of anesthetized dogs.
Satoh E; Mukaiyama O; Kimura T; Satoh S
J Cardiovasc Pharmacol; 1990 Oct; 16(4):661-6. PubMed ID: 1706810
[TBL] [Abstract][Full Text] [Related]
18. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1984 Mar; 228(3):531-6. PubMed ID: 6707908
[TBL] [Abstract][Full Text] [Related]
19. [Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?].
Cice G; Ferrara L; Tagliamonte E; Di Benedetto A; Iacono A
Cardiologia; 1998 Dec; 43(12):1337-43. PubMed ID: 9988942
[TBL] [Abstract][Full Text] [Related]
20. [Cross-over double-blind study of verapamil versus diltiazem in effort myocardial ischemia].
Lablanche JM; Gommeaux A; Fourrier JL; Bertrand ME
Ann Cardiol Angeiol (Paris); 1989 May; 38(5):281-4. PubMed ID: 2735740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
